Latest News

Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders

PHILADELPHIA April 24, 2012 Thomson Reuters Cortellis

World Health Organization’s projection Wendy Hamilton

The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. It is platform independent and accessible via the Internet. Mobile tablet-based devices are the primary method used for accessing the solution.

Users see at-a-glance, side-by-side comparisons of adverse events for drugs already on the market or in clinical trials. They get a deeper understanding of the drugs and how they are being targeted for diseases by segment. The comparisons visualize the level of current research and development activity around an indication, whether by company or mechanism of action, together with information on ongoing clinical trials.

The new applications represent the initial output in an ongoing partnership between Thomson Reuters and AstraZeneca, with other applications due to be released this year. The Thomson Reuters Life Sciences Professional Services team is working on similar innovative projects for other customers too.

Cortellis Cortellis

About Thomson Reuters

New York London Eagan, Minnesota

SOURCE Thomson Reuters

Leave a comment

seks shop - izolasyon
basic theory test book basic theory test